Wargin WA - Search Results

1

Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.

Rowinsky EK, Noe DA, Trump DL, Winer EP, Lucas VS, Wargin WA, Hohneker JA, Lubejko B, Sartorius SE, Ettinger DS, et al. Rowinsky EK, et al. Among authors: wargin wa. J Clin Oncol. 1994 Sep;12(9):1754-63. doi: 10.1200/JCO.1994.12.9.1754. J Clin Oncol. 1994. PMID: 8083697 Clinical Trial.

2

The effects of food and divided dosing on the bioavailability of oral vinorelbine.

Rowinsky EK, Lucas VS, Hsieh AL, Wargin WA, Hohneker JA, Lubejko B, Sartorius SE, Donehower RC. Rowinsky EK, et al. Among authors: wargin wa. Cancer Chemother Pharmacol. 1996;39(1-2):9-16. doi: 10.1007/s002800050532. Cancer Chemother Pharmacol. 1996. PMID: 8995494 Clinical Trial.

3

The clinical pharmacokinetics of vinorelbine (Navelbine).

Wargin WA, Lucas VS. Wargin WA, et al. Semin Oncol. 1994 Oct;21(5 Suppl 10):21-7. Semin Oncol. 1994. PMID: 7973765

4

Phase I and pharmacokinetic study of 502U83 (an arylmethylaminopropanediol) in cancer patients.

Lam KS, Alberts DS, Peng YM, Brodar F, Matias B, Modiano M, Tuttle R, Sol Lucas V, Wargin W. Lam KS, et al. Anticancer Drugs. 1992 Jun;3(3):219-24. doi: 10.1097/00001813-199206000-00003. Anticancer Drugs. 1992. PMID: 1525401

5

Variable first-pass elimination of propranolol following single and multiple oral doses in hypertensive patients.

Wargin WA, Sawchuk RJ, McBride JW, McCoy HG, Rylander ML. Wargin WA, et al. Eur J Drug Metab Pharmacokinet. 1982;7(3):183-9. doi: 10.1007/BF03189564. Eur J Drug Metab Pharmacokinet. 1982. PMID: 7173272

6

Pharmacokinetics of oral and transdermal triprolidine.

Miles MV, Balasubramanian R, Pittman AW, Grossman SH, Pappa KA, Smith MF, Wargin WA, Findlay JW, Poust RI, Frosolono MF. Miles MV, et al. Among authors: wargin wa. J Clin Pharmacol. 1990 Jun;30(6):572-5. doi: 10.1002/j.1552-4604.1990.tb03623.x. J Clin Pharmacol. 1990. PMID: 2355108

7

Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.

Lasseter KC, Shaughnessy L, Cummings D, Pezzullo JC, Wargin W, Gagnon R, Oliva J, Kosutic G. Lasseter KC, et al. J Clin Pharmacol. 2008 Feb;48(2):193-202. doi: 10.1177/0091270007310380. J Clin Pharmacol. 2008. PMID: 18199894 Clinical Trial.

8

Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.

Powell JR, Foster J, Patterson JH, Cross R, Wargin W. Powell JR, et al. Clin Pharm. 1986 Dec;5(12):993-8. Clin Pharm. 1986. PMID: 3802729 Clinical Trial.

9

Importance of the organ-independent elimination of cisatracurium.

Kisor DF, Schmith VD, Wargin WA, Lien CA, Ornstein E, Cook DR. Kisor DF, et al. Among authors: wargin wa. Anesth Analg. 1996 Nov;83(5):1065-71. doi: 10.1097/00000539-199611000-00029. Anesth Analg. 1996. PMID: 8895287

10

Pharmacokinetics of RheothRx injection in healthy male volunteers.

Jewell RC, Khor SP, Kisor DF, LaCroix KA, Wargin WA. Jewell RC, et al. Among authors: wargin wa. J Pharm Sci. 1997 Jul;86(7):808-12. doi: 10.1021/js960491e. J Pharm Sci. 1997. PMID: 9232521 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters